“A lot of insurance payers interpreted this to mean that in order to get covered for the treatment, you also needed to start a new oral antidepressant.” Those requirements can make it more difficult ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

“Spravato ® is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily ...

PE: How does Spravato’s availability as a monotherapy enhance your ability to personalize treatment plans for patients with ... as reflected in numerous patient experiences. For instance, one patient ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral antidepressants.

"Spravato is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days -- without the need for daily oral ...

"Spravato is now available as a stand-alone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days -- without the need for daily oral ...

"SPRAVATO ® is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily oral ...

We are a REMS certified Spravato Treatment Center. For over 25 years, I've cared for people of all ages impacted by traumatic life experiences. I strive to meet mental and behavioral health needs ...